Myocarditis in Clinical Practice.

[1]  G. Sinagra,et al.  Arrhythmic risk prediction of acute myocarditis presenting with life-threatening ventricular tachyarrhythmias. , 2016, International journal of cardiology.

[2]  B. Schnackenburg,et al.  Performance of T1 and T2 Mapping Cardiovascular Magnetic Resonance to Detect Active Myocarditis in Patients With Recent-Onset Heart Failure , 2015, Circulation. Cardiovascular imaging.

[3]  W. Hoffmann,et al.  Analysis of endomyocardial biopsies in suspected myocarditis--diagnostic value of left versus right ventricular biopsy. , 2014, International journal of cardiology.

[4]  G. Schuler,et al.  The potential additional diagnostic value of assessing for pericardial effusion on cardiac magnetic resonance imaging in patients with suspected myocarditis. , 2014, European heart journal cardiovascular Imaging.

[5]  C. Catalano,et al.  CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis. , 2014, JACC. Cardiovascular imaging.

[6]  G. Barbati,et al.  Long-Term Evolution and Prognostic Stratification of Biopsy-Proven Active Myocarditis , 2013, Circulation.

[7]  E. Fabris,et al.  Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. , 2013, The American journal of cardiology.

[8]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[9]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[10]  A. Frustaci,et al.  Contribution and Risks of Left Ventricular Endomyocardial Biopsy in Patients With Cardiomyopathies: A Retrospective Study Over a 28-Year Period , 2013, Circulation.

[11]  V. Kytö,et al.  The effects of gender and age on occurrence of clinically suspected myocarditis in adulthood , 2013, Heart.

[12]  Tiina Heliö,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[13]  M. Emdin,et al.  Myocardial Fibrosis as a Key Determinant of Left Ventricular Remodeling in Idiopathic Dilated Cardiomyopathy: A Contrast-Enhanced Cardiovascular Magnetic Study , 2013, Circulation. Cardiovascular imaging.

[14]  G. Ligabue,et al.  Good Prognosis for Pericarditis With and Without Myocardial Involvement: Results From a Multicenter, Prospective Cohort Study , 2013, Circulation.

[15]  S. Russell,et al.  Evaluation of the Role of Endomyocardial Biopsy in 851 Patients With Unexplained Heart Failure From 2000–2009 , 2013, Circulation. Heart failure.

[16]  G. Sinagra,et al.  Clinical presentation and long-term follow-up of perimyocarditis , 2013, Journal of cardiovascular medicine.

[17]  J. Kautzner,et al.  Utility of combination of cardiac magnetic resonance imaging and high-sensitivity cardiac troponin T assay in diagnosis of inflammatory cardiomyopathy. , 2013, The American journal of cardiology.

[18]  B. Carter.  2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology , 2013 .

[19]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[20]  M. Giacca,et al.  Idiopathic dilated cardiomyopathy and persistent viral infection: lack of association in a controlled study using a quantitative assay. , 2012, Heart, lung & circulation.

[21]  H. Schultheiss,et al.  Interferon-Beta improves survival in enterovirus-associated cardiomyopathy. , 2012, Journal of the American College of Cardiology.

[22]  A. Angelini,et al.  2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. , 2012, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[23]  J. Kautzner,et al.  Detection of Borrelia burgdorferi sensu lato in endomyocardial biopsy specimens in individuals with recent‐onset dilated cardiomyopathy , 2012, European journal of heart failure.

[24]  S. Gallagher,et al.  Diagnosis and management of patients with acute cardiac symptoms, troponin elevation and culprit-free angiograms , 2012, Heart.

[25]  G. Schuler,et al.  Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. , 2012, JACC. Cardiovascular imaging.

[26]  K. Klingel,et al.  Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. , 2012, Journal of the American College of Cardiology.

[27]  S. Heymans,et al.  Differences in virus prevalence and load in the hearts of patients with chronic dilated cardiomyopathy with and without immune-mediated inflammatory disease , 2010, Clinical and Vaccine Immunology.

[28]  M. Böhm,et al.  Prognostic electrocardiographic parameters in patients with suspected myocarditis , 2011, European journal of heart failure.

[29]  M. Böhm,et al.  Virus serology in patients with suspected myocarditis: utility or futility? , 2011, European heart journal.

[30]  M. Schieber,et al.  Comparative Evaluation of Left and Right Ventricular Endomyocardial Biopsy: Differences in Complication Rate and Diagnostic Performance , 2010, Circulation.

[31]  S. Heymans,et al.  Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load , 2010, Antiviral therapy.

[32]  M. Cheitlin.  Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study , 2010 .

[33]  Andrea Frustaci,et al.  Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. , 2009, European heart journal.

[34]  Michael Böhm,et al.  Predictors of Outcome in Patients With Suspected Myocarditis , 2008, Circulation.

[35]  S. Heymans,et al.  Acute viral myocarditis , 2008, European heart journal.

[36]  M. Gutberlet,et al.  Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. , 2008, Radiology.

[37]  Renu Virmani,et al.  A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology , 2022 .

[38]  A. Angelini,et al.  A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. , 2007, European heart journal.

[39]  J. Magnani,et al.  Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors. , 2006, American heart journal.

[40]  K. Baughman.  Diagnosis of myocarditis: death of Dallas criteria. , 2006, Circulation.

[41]  WolfgangPoller,et al.  High Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of Adults With “Idiopathic” Left Ventricular Dysfunction , 2005 .

[42]  R. Kandolf,et al.  High Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of Adults With “Idiopathic” Left Ventricular Dysfunction , 2005, Circulation.

[43]  A. di Lenarda,et al.  Fatal myocarditis: morphologic and clinical features. , 2004, Italian heart journal : official journal of the Italian Federation of Cardiology.

[44]  K. Klingel,et al.  Parvovirus B19 Infection Mimicking Acute Myocardial Infarction , 2003, Circulation.

[45]  Romuald Wojnicz,et al.  Randomized, Placebo-Controlled Study for Immunosuppressive Treatment of Inflammatory Dilated Cardiomyopathy: Two-Year Follow-Up Results , 2001, Circulation.

[46]  R. Holubkov,et al.  Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy , 2001, Circulation.

[47]  R. Hruban,et al.  Echocardiographic findings in fulminant and acute myocarditis. , 2000, Journal of the American College of Cardiology.

[48]  G. Hufnagel,et al.  The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID) First Epidemiological Results , 2000, Herz.

[49]  R H Hruban,et al.  Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. , 2000, The New England journal of medicine.

[50]  R. Hruban,et al.  Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. , 2000, The New England journal of medicine.

[51]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[52]  B. McManus,et al.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. , 1995, The New England journal of medicine.

[53]  F. Camerini,et al.  Echocardiographic findings in myocarditis. , 1988, The American journal of cardiology.

[54]  P. Quigley,et al.  Long-term follow-up of acute myocarditis. Correlation of ventricular function and outcome , 1987 .

[55]  W. Edwards,et al.  Myocarditis. A histopathologic definition and classification. , 1987, The American journal of cardiovascular pathology.